Cell Culture Market Worth $48.63 Billion by 2029

According to a new market research report titled, ‘Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, Academic) – Global Forecast to 2029,’ published by Meticulous Research®, the cell culture market is expected to grow at a CAGR of 11.7% from 2022 to 2029, to reach $48.63 billion by 2029.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4788

A major factor contributing to the growth of this market is the increasing prevalence of chronic diseases. Hence, research studies are carried out for the treatment of these diseases. The drug development-related research studies involve cell culture techniques. Furthermore, the aging population increases the chances of age-related chronic diseases, further driving the market growth.

Additionally, there has been an increase in the adoption of single-use technology due to its advantages compared to other conventional technology, such as pre-sterilized condition, no post-process cleaning of the system, and less contamination. These factors further propel the demand for cell culture products.

Additionally, the growing adoption of 3D cell culture and the growth potential of personalized medicine are expected to offer significant growth opportunities for the players operating in the cell culture market.

The cell culture market is segmented by product [consumables (media {cell culture media, by physical form–dry powder media, liquid media}, {cell culture media, by type–off-the-shelf media, custom media}, {cell culture media; source-chemically defined media, serum-free media, classical media, xeno-free/animal component free, other cell culture media}), reagents (growth factors and cytokines, cryoprotective reagents, antibiotics/ antimycotics, cell dissociation reagents, buffers, balanced salt solutions, attachment and matrix factors, other cell culture reagents), cells and cell lines, sera (fetal bovine serum, other sera), cell culture vessels (cell culture dishes, cell culture plates, cell culture flasks, roller bottles, other cell culture vessels)) equipment (cryopreservative containers, refrigerators and freezers, biosafety cabinets, incubators, sterilizers, bioreactors, microscopes, centrifuges, cell counters, water baths, other equipment)]; application [bioproduction (monoclonal antibody production, therapeutic protein production, vaccine production, cell and gene therapy)], diagnostics, cancer research, drug screening and development, stem cell research); end user (pharmaceutical and biotechnology companies, academic and research institutes, diagnostic laboratories); and geography (North America, Europe, Asia-Pacific, Latin America, and MEA). The study also evaluates industry competitors and analyzes their market shares at country and regional levels.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=4788

Based on product, in 2022, the consumables segment is estimated to account for the largest share of the cell culture market. The segment is also expected to register the highest CAGR during the forecast period. The major factor contributing to the segment’s lucrative growth is the adoption of cell culture techniques for various applications in the life science sectors such as cancer research, stem cell research, bioproduction, and diagnosis. Hence, the recurrent use of consumables for research studies and production facilities.

Based on application, the bioproduction segment is expected to register the highest CAGR during the forecast period. Bioproduction includes monoclonal antibody production, therapeutic protein production, vaccine production, and cell and gene therapy. These applications are gaining popularity due to their effectiveness in treating diseases. Moreover, vaccine production was at a higher rate during the pandemic. Due to their effectiveness, an increase in approvals for monoclonal antibodies was also observed during the pandemic, contributing to the growth of this segment.

Quick Buy – Cell Culture Market Research Report: https://www.meticulousresearch.com/Checkout/94004198

Based on end user, the pharmaceutical and biotechnology companies segment is expected to register the highest growth rate during the forecast period. The major factor contributing to the growth of this segment is the rise in R&D spending of these companies for drug discovery and developments, vaccine production, and cancer cells. Additionally, these companies use cell culture products to produce biomolecules, further leading to market growth.

Based on geography, Asia-Pacific is expected to register the highest growth rate during the forecast period. Major factors contributing to the growth of this segment are the expansion of the biopharma and pharma companies in the region, an increase in the funding for research studies, and the growing number of clinical research activities.

Some of the key players operating in the cell culture market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Miltenyi Biotec B.V. & Co. KG (Germany), and Solida Biotech GmbH (Germany).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/cell-culture-market-4788

Scope of the Report:

Cell Culture Market, by Product

• Consumables
  • Media
    • Cell Culture Media Market, by Physical Form
      • Dry Powder Media
      • Liquid Media
    • Cell Culture Media Market, by Type
      • Off-the-Shelf Media
      • Custom Media
    • Cell Culture Media Market, by Source
      • Chemically Defined Media
      • Serum-free Media
      • Classical Media
      • Xeno-free/Animal Component Free
      • Other Cell Culture Media
  • Reagents
    • Growth Factors and Cytokines
    • Cryoprotective Reagents
    • Antibiotics/ Antimycotics
    • Cell Dissociation Reagents
    • Buffers
    • Balanced Salt Solutions
    • Attachment and Matrix Factors
    • Other Cell Culture Reagents

                    (Other cell culture reagents include chelators, antioxidants, sugars, vitamins, stains, and dyes)

• • Cells and Cell Lines
  • Sera
    • Fetal Bovine Serum
    • Other Sera

                    (Other sera include newborn calf serum, chicken serum, goat serum, rabbit serum, pig serum, mouse serum, sheep serum, rat serum, and horse serum)

• • Cell Culture Vessels
    • Cell Culture Dishes
    • Cell Culture Plates
    • Cell Culture Flasks
    • Roller Bottles
    • Other Cell Culture Vessels

                    (Other cell culture vessels include pipettes, tips, cuvettes, and tubings)

• Equipment
  • Cryopreservative Containers
  • Refrigerators and Freezers
  • Biosafety Cabinets
  • Incubators
  • Sterilizers
  • Bioreactors
  • Microscopes
  • Centrifuges
  • Cell Counters
  • Water Baths
  • Other Equipment

               (Other equipment includes scales, weighing balance, and pH meter)

Cell Culture Market, by Application

• Bioproduction
  • Monoclonal Antibody Production
  • Therapeutic Protein Production
  • Vaccine Production
  • Cell and Gene therapy
• Diagnostics
• Cancer Research
• Drug Screening and Development
• Stem Cell Research

Cell Culture Market, by End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Diagnostic Laboratories

Cell Culture Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4788

Diabetes Care Devices Market Worth $31.9 Billion by 2028 – Exclusive Report by Meticulous Research®

 According to a new market research report, titled “Diabetes Care Devices Market by Type [Diabetes Monitoring (CGM, Test Strips, Self-Monitoring Blood Glucose Meters, Lancets, Haemoglobin A1C Testing Kits)], [Insulin Delivery (Syringes, Pens, Pumps, Jet Injectors)] – Global Forecast to 2028” published by Meticulous Research®, the diabetes care devices market is expected to grow at a CAGR of 6.7% from 2021 to reach $31.9 billion by 2028.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438

As the prevalence of diabetes is increasing globally, self-management of diabetic treatments has become necessary to avoid long-term complications and fatalities. Diabetes care devices play an important role in managing diabetes as they enable patients to record and track their blood glucose levels all day long and administer the insulin doses according to the insulin levels.

The key factors driving the overall diabetes care devices market are the rising obesity cases, unhealthy and sedentary lifestyle, increasing prevalence of diabetes, and development of new insulin delivery systems. However, some limitations of diabetes care devices are their high costs and accessibility in low-middle income countries.

Impact of COVID-19 on Diabetes Care Devices Market

The COVID-19 pandemic has severely impacted the diabetes care devices market. COVID-19 patients had higher blood glucose levels due to the use of steroids for the COVID-19 treatment. In 2020, the increase in the number of individuals suffering from diabetes due to COVID-19 expanded the income of the central participants in the diabetes care division. Many players in the market presented new progressed diabetes care devices and association arrangements for diabetes care devices.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3438

Diabetes Care Devices Market Overview

The diabetes care devices market is segmented based on type: (diabetes monitoring devices and insulin delivery devices) and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).  The study also evaluates industry competitors and analyzes their market share at a global level.

In 2021, the diabetes monitoring devices segment is estimated to account for the largest share of the overall diabetes care devices market. This is mainly attributed to the increased adoption of test strips and self-monitoring blood glucose meters and increasing demand for continuous glucose monitoring with rising awareness towards the disease in developing countries. Diabetes monitoring devices can be utilized to monitor blood glucose values and help the patient adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a regular basis.

Diabetes monitoring devices are further segmented into continuous blood glucose monitoring devices, test strips, lancets, self-monitoring blood glucose meters, and hemoglobin A1C testing kits. The test strips segment is expected to dominate the diabetes monitoring devices market in 2021, primarily due to the frequent usage of test strips for both continuous and self-glucose monitoring and is widely used by patients in developing countries.

Moreover, insulin delivery devices also are further segmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. In 2021, the insulin pens segment is expected to dominate the insulin delivery devices market. This can be primarily attributed to its advantages over traditional syringe insulin delivery methods, including improved patient satisfaction and adherence, user-friendly, greater ease of use, superior accuracy for delivering small insulin doses, greater social acceptability, and less reported injection pain. However, insulin pumps are the fastest-growing segment due to the advantages such as predictable insulin delivery, precise delivery of insulin, and reduction of wide fluctuation in blood glucose. It also mimics the normal pancreas’s release of insulin.

Quick Buy – Diabetes Care Devices Market Research Report: https://www.meticulousresearch.com/Checkout/33395503

Geographically, in 2021, North America is estimated to account for the largest share of the global diabetes care devices market, followed by Europe and Asia-Pacific. Factors such as the increasing prevalence of diabetes with the rising need to self-monitor and treat the disease, increasing prevalence of major risk factors of diabetes such as obesity and sedentary lifestyle, increasing geriatric population, and growing government initiatives promoting diabetes care are driving the growth of the diabetes care devices market in North America. However, Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in this market is expected to be driven by the increasing prevalence of diabetes with the rising need to self-monitor the treatments, increasing prevalence of obesity and sedentary lifestyle, growing geriatric population, and government initiatives promoting diabetes care.

The report also includes an extensive assessment of the key strategic developments of leading market participants in the industry over the past four years. In recent years, the diabetes care devices market has witnessed several new product launches, approvals, agreements, collaborations, partnerships, expansions, and acquisitions. For instance, in May 2021, Medtronic PLC (Ireland) received CE Mark approval for the expanded functionality of its InPen and Guardian 4 sensors. Moreover, in February 2020, Abbott Laboratories (U.S.) partnered with Insulet Corporation (U.S.) to combine its leading continuous glucose monitoring (CGM) technology with Insulet’s Omnipod Horizon Automated Insulin Delivery System.

Some of the key players operating in the global diabetes care devices market are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan IP Holdings, LLC (U.S.), Medtronic PLC (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Sanofi AS (France), and DexCom, Inc. (U.S.), among others.

The diabetes care devices market is dominated by Abbott Laboratories (U.S.), Medtronic PLC (Ireland), DexCom, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Ascensia Diabetes Care (Switzerland), LifeScan IP Holding, LLC (U.S.), Becton, Dickinson and Company (U.S.), Insulet Corporation (U.S.), Novo Nordisk A/S (Denmark), and Tandem Diabetes Care, Inc. (U.S.). Together, these companies held around 80% share of the global diabetes care devices market in 2020.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/diabetes-care-devices-market-3438

Scope of the Report:

Diabetes Care Devices Market, by Type

• Diabetes Monitoring Devices
• Insulin Delivery Devices

Diabetes Care Devices Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438

Disinfection Robots Market Growing at a CAGR of 30.1% to Reach 2.79 Billion by 2028

 In its latest publication on the disinfection robots market, Meticulous Research®, states that the global disinfection robots market is expected to grow at a CAGR of 30.1% from 2021 to 2028 to reach $2.79 billion.

This market is driven by the increasing prevalence of hospital-acquired infections and the advantages offered by disinfection robots over manual disinfection. Furthermore, emerging economies and technological advancements in the field of robotics are expected to provide the industry with significant potential prospects in the future. However, the limitations of disinfection robots may hinder the growth of this market. Also, the high initial investment coupled with additional repair & maintenance costs poses a major challenge for the growth of this market.

Get Inside Scoop Of The Report, Download For Free Sample PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5234

To provide efficient analysis, Meticulous Research® has segmented this market based on type, technology, end user, and geography. The study also evaluates industry competitors and analyzes the market at the country level.

In 2021, based on type, the ultraviolet light disinfection robots segment is estimated to account for the largest share of the market. The large market share of this segment is attributed to the advantages of ultraviolet light disinfection robots in disinfecting hospital rooms with great efficiency and minimal need for manual intervention.

Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5234

In 2021, based on technology, the fully autonomous disinfection robots segment is estimated to account for the largest share of the overall market. The large market share of this segment is attributed to the technologically advanced features of fully autonomous disinfection robots, with self-navigation and smart decision-making capabilities.

The report provides competitive intelligence in terms of financials, growth strategies, type, technology, end user, and geographical presence on some of the key players in this market, including SESTO Robotics Pte. Ltd. (Singapore), UVD Robots (Denmark), PDI, Inc. (U.S.), Xenex Disinfection Services Inc. (U.S.), Nevoa Inc. (U.S.), Badger Technologies LLC (U.S.), Skytron, LLC (U.S.), Omron Corporation (Japan), Fetch Robotics, Inc. (U.S.), Finsen Technologies Ltd (U.K.), Taimi Robotics Technology Co. Ltd (China), Akara Robotics Ltd. (Ireland), Siemens AG (Germany), and Milagrow Business & Knowledge Solutions (Pvt.) Limited (India).

Speak to our Analysts to Understand the In Detail Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5234

Plasma Fractionation Market Worth $46.9 Billion by 2029

 

 

According to a new market research report, “Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, Subcutaneous), Coagulation Factors, Albumin], Application (Immunology, Hematology, Neurology), and End User (Hospital, Clinical Research Lab, Academic Institutes) — Global Forecast to 2029”, published by Meticulous Research®, the plasma fractionation market is expected to grow at a CAGR of 7.1% from 2022 to reach $46.9 billion by 2029.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5117

Some of the key players operating in this market are CSL Limited (Australia), Grifols, S.A. (Spain), Octopharma AG (Switzerland), Kedrion S.P.A. (Italy), Shire plc (U.K.), Biotest AG (Germany), China Biologic Products Holdings, Inc. (China), Bio Products Laboratory Ltd (U.K.), Japan Blood Products Organization (Japan), and Intas Pharmaceuticals Ltd. (India).

The report also includes an extensive assessment of the product portfolio, geographic analysis, and key strategic developments in the industry’s leading market participants over the past four years (2019–2022). In recent years, the plasma fractionation market has witnessed several product approvals, new product launches, partnerships, agreements, & collaborations, expansions, and acquisitions. For instance, in February 2022, Grifols, S.A. (Spain) entered into an agreement with Endpoint Health, Inc. (U.S.) to develop and commercialize an Antithrombin III (AT-III) therapy to treat Sepsis. Also, in August 2021, Octopharma AG (Switzerland) received U.S. FDA approval for Octagam 10% [Immune Globulin Intravenous (Human)] for the treatment of adult dermatomyositis (DM).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/plasma-fractionation-market-5117

Scope of the Report:

Plasma Fractionation Market, by Product

• Immunoglobulins
• Intravenous Immunoglobulins
• Subcutaneous Immunoglobulins
• Intramuscular Immunoglobulins
•  
• Coagulation Factors
• Albumin
• Protease Inhibitors
• Others

Note: Other plasma-derived products include fibrin, sealant, and plasma.

Plasma Fractionation Market, by Application

• Immunology
• Hematology
• Neurology
• Critical Care
• Hemato-Oncology
• Rheumatology
• Others

Note: Other applications include management of respiratory diseases and wound healing.

Plasma Fractionation Market, by End User

• Hospitals& Clinics
• Clinical Research Laboratories
• Academic Institutes

Plasma Fractionation Market, by Geography

• North America
• U.S.
• Canada
•  
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe (RoE)
•  
• Asia-Pacific (APAC)
• China
• Japan
• India
• Rest of APAC (RoAPAC)
•  
• Latin America
• Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5117

Spirulina Market Worth $629.6 Million by 2025

 

Meticulous Research® in collaboration with the European Algae Biomass Association (EABA), published a new market research report titled, “Spirulina Market by Distribution Channel (Consumer Channel, Business Channel), Product Type (Powder, Tablets, Capsules, Flakes, Phycocyanin Extract), and Application (Nutraceuticals, Food & Beverages, Agriculture, Animal Feed)- Global Forecast to 2025”. Combining Meticulous Research®’s market intelligence services with EABA’s broad expertise in the development of research, technology, and industrial capacities in the field of spirulina, the two organizations have leveraged their research capabilities to come up with the most reliable and accurate market assessments in this field.

According to the report, the global spirulina market is expected to grow at a CAGR of 9.4% from 2019 to reach $629.6 million by 2025. In terms of volume, the spirulina market is expected to grow at a CAGR of 13.6% from 2019 to reach 68,025.2 tons by 2025.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5070

The growth of the spirulina market is mainly attributed to growing health & wellness trends and dietary supplements industry, growing demand for natural food colors, increasing vegetarianism, and growing malnutrition. Moreover, factors such as stringent regulations regarding the inclusion of synthetic colors and flavors; increasing preference for spirulina sourced products, especially pigments and omega-3 fatty acids; growing use of spirulina in aquaculture diets; and increase in number of products that include spirulina as ingredients across the globe further support the growth of the global spirulina market.

Spirulina is very sensitive to different frameworks and its price depends on the various factors such as quantity, drying process, form, packaging, certification, origin, quality/contamination, negotiation capacity, and specific spirulina (if enriched with selenium, it is more expensive). The prices have dropped in the last few years, as the production systems have become scalable; however, production costs are still high in developed countries as compared to emerging countries due to unfavorable climatic conditions and the use of expensive production technologies.

The global spirulina market study presents historical market data in terms of value (2017 and 2018), estimated current data (2019), and forecasts for 2025-by distribution channel (consumer channel, business channel), product type (powder, tablets, capsules, flakes, and phycocyanin extract), and application (nutraceuticals, food & beverages, agriculture, animal feed, and cosmetics). The study also evaluates industry competitors and analyzes the market at a regional and country level.

The key players operating in the global spirulina market are Earthrise Nutritional, LLC (U.S.), DIC Corporation (Japan), Yunnan Green A Bio-engineering Co., Ltd (China), Algene Biotech (India), Tianjin Norland Biotech Co., Ltd. (China), Pondicherry Spirulina Farms (India), Cyanotech Corporation (U.S.), E.I.D. Parry (I) Ltd. (India), Far East Bio-Tec. Co. Ltd. (China), Fuqing King Dnarmsa Spirulina Co., Ltd. (China), Dongtai City Spirulina Bio-engineering Co., Ltd. (China), and Australian Spirulina (Australia) among others.

Browse key industry insights spread across 263 pages with 195 market data tables & 55 figures & charts from the market research report: https://www.meticulousresearch.com/product/spirulina-market-5070/

Pharmaceutical Storage and Material Handling Equipment Market Worth 1,597.4 Million USD by 2023

 According to the latest publication from Meticulous Research®, the global pharmaceutical storage and material handling equipment market is expected to grow at a CAGR of 8.6% from 2018 to reach USD 1,597.4 million in 2023. The growth of this market will be driven by factors such as rapid growth of the pharmaceutical industry, increasing focus of manufacturers on reduction of production cost, government support to promote the pharmaceutical sector, growing demand of single use systems, and increasing focus towards automation in the pharmaceutical industry. However, demand for refurbished machines hamper the growth of this market. As consolidations in the pharmaceutical industry occur and more and more machines are released within companies and in the market, the ability to use available pre-owned machines is becoming more prominent. Also, many major organizations return their pharmaceutical processing machines back to the vendor for various reasons like malfunctions, speed issue etc. These returned products are tested for functionality and defects; they are hence refurbished and resold to the small setups for the manufacturing and handling of pharma products.

Request Sample Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=4364

Geographically, North America commanded the largest share of the global market, mainly due to its huge pharma manufacturing sector, high adoption rate of automation in the pharmaceutical industry, innovations and advancements in bulk material handling products and technologies, and implementation of some expansions and acquisitions plans by the leading pharmaceutical storage and material handling systems manufacturers to increase production capacity.

The major players operating in this market are SERVOLiFT GmbH, Mueller GmbH, Hanningfield Process Systems Ltd., GEA Group Aktiengesellschaft, AZO GmbH + Co. KG, David Round Company, Inc, FLEXICON Corporation, Spirotech-SRD Group Ltd., VAC-U-MAX, Dietrich Engineering Consultants S.A., Volkmann, Inc, Schenck Process Holding GmbH, Coperion Capital GmbH, Matcon Ltd., Gough Econ, Inc, Guttridge Limited, and Glatt GmbH.

The transport systems market dominated the global pharmaceutical storage and material handling equipment market, mainly due to the increasing use of automated and semi-automated transport systems to meet GMP standards. This market is also expected to increase significantly during the forecast period with the growing demand for smaller lot sizes; shorter lead times; and higher quality products, especially in developing countries.

Browse in-depth report on: https://www.meticulousresearch.com/product/pharmaceutical-storage-material-handling-equipment-market/

Oilfield Services Market is Expected to Grow at a CAGR of 3.6% to Reach $171.7 Billion by 2025

 

 

Traditional oilfield services (OFS) operating models are now being completely disrupted by the technological advancements with the increasing use of internal sources of funding. In recent years, these factors have given a new edge to the entire oil industry, which now competes with additional parameters than pricing. Hence, tech advancement has helped oil & gas companies in transforming their businesses from product selling to advisory selling.

According to a new market research report “Oilfield Services Market by Type (Pressure Pumping, Oil Country Tubular Goods, Well Intervention and Coiled Tubing, Drilling and Completion Fluid, Well Completion, Seismic Testing), Location (Onshore and Offshore), and Geography — Global Forecast to 2025” published by Meticulous Research®, the oilfield services market is expected to grow at a CAGR of 3.6% from 2019 to reach $171.7 billion by 2025.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4963

The growth of the global oilfield services market is mainly attributed to the increasing adoption of technology-driven models, rising geographically dispersed operations, and increased presence in service segments such as offshore operations. However, the price war amongst the leading oil supplying countries across the globe along with the strict government regulations on E&P activities is expected to impact the revenue of this market.

List of the Key Companies Operating in the Oilfield Services Market:

• Schlumberger Limited (U.S.)
• Baker Hughes GE (U.S.)
• Halliburton Company (U.S.)
• Weatherford International, PLC (U.S.)
• China Oilfield Services Limited (COSL) (China)
• Basic Energy Services (U.S.)
• Superior Energy Services, Inc. (U.S.)
• FMC Technologies, Inc. (U.S.)
• Welltec (Denmark)
• The Weir Group PLC (U.K.)
• National Oilwell Varco (U.S.)
• Oil States International, Inc. (U.S.)
• Archer Limited (Bermuda)

Get Detailed Insights of This Research with Table of Content: https://www.meticulousresearch.com/product/oilfield-services-market-4963/

Key questions answered in the report-

• Which are the high growth market segments in terms of service type, location, and region?
• What was the historical market for oilfield services across the globe?
• What are the market forecasts and estimates for the period 2019–2025?
• What are the major drivers, restraints, and opportunities in the global oilfield services market?
• Who are the major players in the global oilfield services market?
• How is the competitive landscape and who are the market leaders in the global oilfield services market?
• What are the recent developments in the global oilfield services market?
• What are the different strategies adopted by the major players in the global oilfield services market?
• What are the geographical trends and high growth regions?
• Who are the local emerging players in the global oilfield services market and how do they compete with the global players?

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4963

Downstream Bio-processing Controllers Market Worth $1.92 billion by 2025

 According to a new market research report, “Downstream Bio-processing Controllers Market by Procedure (Chromatography, TFF), Product (Chromatography Controller System, TFF Controller System, Disposable Flow Path], Application (Commercial, Research), and End User– Global Forecasts to 2025”, published by Meticulous Research®, the global downstream bio-processing controllers market is expected to grow at a CAGR of 17.3% from 2019 to reach $1.92 billion by 2025.

Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5033

Downstream bio-processing is a process in biopharmaceutical manufacturing involving the recovery of pure protein such as biopharmaceuticals, vaccines, and other biologics from contaminant proteins. The purification process involves extraction, adsorption, filtration, precipitation, virus removal, and polishing of the product by chromatography of filtration to procure quality biopharmaceutical product. Owing to growing demand for biopharmaceuticals, rising adoption of single-use bio-processing equipment and consumables, and capacity expansion by biopharmaceutical manufacturers- this industry has witnessed a steady growth. For instance, according to contract pharma and BioProcess International magazine, the bioprocessing facilities and capacities are increasing rapidly worldwide. According to the estimations, the total worldwide bio-manufacturing capacity of contract manufacturing organizations was 2,062,000 litres in 2008, which increased by ~68% reaching 3,455,267 litres by 2018. In addition, with consistently growing demand for biopharmaceuticals in the U.S., the total number of biosimilars approved till June 2019 reached count of 21 as compared to 1 in 2015. Similarly, according to Personalized Medicine Coalition, globally, the number of commercially available personalized medicines in the market has increased from 5 in 2008 to 148 in number in 2017.

The global downstream bio-processing controllers market study presents historical market data in terms of value and volume (2017 and 2018), estimated current data (2019), and forecasts for 2025-by procedure (chromatography, TFF), product [chromatography controller system, chromatography disposable flow path, TFF controller system, and TFF disposable flow path], application (commercial, research), end user (pharmaceutical & biotechnology companies, contract manufacturing organizations, and academic & research institutes), and geography. The study also evaluates industry competitors and analyzes the market at regional and country level.

Browse key industry insights spread across 192 pages with 164 market data tables & 52 figures & charts from the report: https://www.meticulousresearch.com/product/downstream-bio-processing-controllers-market-5033/

Based on procedure, the tangential flow filtration (TFF) procedure segment is estimated to account for the largest share of the overall downstream bio-processing controllers market in 2019. The large share of this segment is mainly attributed to higher adoption of TFF procedures to obtain pure biopharmaceutical products without affecting the quality.

Based on product type, Tangential Flow Filtration (TFF) products (including TFF Controller System and TFF disposable flow path) accounted for the largest share of the overall downstream bio-processing controllers market in 2018. The large share of this segment is mainly attributed to rising adoption of TFF procedures with single use technology to purify protein products with reduced capital investment and time. On the other hand, chromatography products (chromatography controller system and chromatography disposable flow path) are slated to grow at the fastest CAGR during the forecast period due to higher preference for chromatography procedures in small and medium scale bio-production industries.

Based on application, commercial bioprocessing segment is estimated to account for the largest share of the overall downstream bio-processing controllers market in 2019 and is also slated to grow at the fastest CAGR during the forecast period. The major share of this segment is primarily attributed to growing demand for biopharmaceuticals and on-going as well as future capacity expansions from various biopharmaceutical manufacturers.

Based on end user, pharmaceutical & biotechnology companies segment is estimated to account for the largest share of the overall downstream bio-processing controllers market in 2019. The major share of this segment is primarily attributed to high requirement of bio-processing equipment and consumables and greater purchasing power of pharmaceutical and biotechnology companies as compared to the other end users. On the other hand, contract development and manufacturing organizations segment is slated to grow at the fastest CAGR, mainly attributed to growing trend towards outsourcing of biologics manufacturing and favorable regulatory reforms for CDMOs.

The report includes extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016–2019). The downstream bio-processing controllers market has witnessed number of partnerships, agreements, and collaborations in recent years. For instance, in November 2018, GE Healthcare collaborated with Wego Pharmaceutical Co. Ltd (China) for the manufacturing of single-use consumable products for bioprocessing in China. Similarly, in March 2019, Pall Corporation (a subsidiary of Danaher) signed an agreement with ARTeSYN Biosolutions (Ireland) to expedite the implementation of robust and standardized single-use fluid management and control systems.

Get Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5033

Agricultural Fumigants Market Worth $1.9 Billion by 2025

 According to a new market research report “Agricultural Fumigants Market by Type (Phosphine, Chloropicrin, Telone, Metam Sodium), Application (Warehouse, Soil), Form (Liquid, Solid), Pest Control Method (Tarpaulin Fumigation, Structural Fumigation (Tent)), and Crop Type — Global Forecast to 2025”, published by Meticulous Research®, the global agricultural fumigants market is expected to grow at a CAGR of 4.6% from 2019 to reach $1.9 billion by 2025.

In order to fulfill the food demand of growing population, advanced productive agricultural materials are required. Over the last several decades, there have been tremendous efforts followed to improve agricultural yields through adoption of new technologies and use of crop protection products. The crop protection products including phosphine, chloropicrin, 1,3-dichloropropene, and metam sodium, among others are used to suppress, control or repel pests attacking on seeds, seedling, plants, and stored agriculture commodities. The innovation and adoption of the advanced fumigators and safety measures have boosted the application of fumigants in soil and in closed structure, ultimately driving the demand of fumigants across the globe.

Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=4263

Geographically, the global agricultural fumigants market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The North America is estimated to command the largest share of the global agricultural fumigants market in 2019, mainly due to rising reduction in arable land, adoption of improved agriculture practices, presence of key crop protection chemical manufacturers, increasing need for sustainable agriculture, higher efficiency of fumigants in terms of application, and increasing adoption of fumigants in the food stock warehouses.

Scope of the report:

Agricultural Fumigants Market by Type

• Phosphine
• Chloropicrin
• 1,3-Dichloropropene
• Metam Sodium
• Others

Agricultural Fumigants Market by Application

• Warehouse
• Soil

Agricultural Fumigants Market by Form

• Liquid
• Solid
• Gaseous

Agricultural Fumigants Market by Crop Type

• Grains and Cereals
• Oilseeds and Pulses
• Fruits & Vegetables
• Turf & Ornaments
• Others

Agricultural Fumigants Market by Pest Control Method

• Tarpaulin Fumigation
• Structural Fumigation (Tent)
• Vacuum Chamber Fumigation
• Others

Agriculture Fumigants Market by Geography

• North America
• U.S.
• Canada
• Mexico
• 
  
• Europe
• Spain
• France
• Italy
• Germany
• U.K.
• Rest of Europe (RoE)
• 
  
• Asia-Pacific (APAC)
• China
• India
• Japan
• Australia
• Rest of Asia-Pacific (RoAPAC)
• 
  
• Rest of World
• Latin America
• Brazil
• Argentina
• Chile
• Rest of Latin America (RoLATAM)
• 
  
• Middle East and Africa
• 
  

Get Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4263

The key players operating in the global agricultural fumigants market are Dow Chemical Company (U.S.), Syngenta International AG (Switzerland), Nufarm Limited (Australia), AMVAC Chemical Corporation (U.S.), ADAMA Agricultural Solutions Ltd. (Israel), BASF SE (Germany), UPL Limited (India), Marrone Bio Innovations, Inc. (U.S.), Isagro S.p.A. (Italy), Arkema Group (France), Solvay group (Belgium), Eastman Chemical Company (U.S.), DEGESCH America, Inc. (U.S.), Reddick Fumigants, LLC (U.S.), and Vietnam Fumigation J.S Company (Vietnam).

Browse key industry insights spread across 212 pages with 157 market data tables & 47 figures & charts from the report: https://www.meticulousresearch.com/product/agricultural-fumigants-market/

Non-Invasive Prenatal Testing (NIPT) Market Worth $13.14 Billion by 2027, Growing at a CAGR of 17.1% from 2019

 

 

The non-invasive prenatal testing market is expected to grow at a CAGR of 17.1% from 2019 to 2027 to reach $13.14 billion by 2027.

With the emergence of innovative diagnostic and screening techniques, several methods of genetic testing are gaining popularity. These include carrier testing, preimplantation genetic diagnosis / screening (PGD / PGS), non-invasive prenatal testing (NIPT), paternity testing, and newborn screening. Technological advancements in the healthcare industry such as wearable healthcare devices, sequencing technologies, regenerative medicine, and genomic technologies, supported by breakthroughs in the field of genome sequencing and molecular research have opened new and promising pathways to combat genetic diseases and reduce the overall global economic burden.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5068

Among the innumerable advancements witnessed by the industry, non-invasive prenatal testing stands as one of the most distinctive technologies in curbing the concerns related to genetic diseases. NIPT a novel genetic screening method based on the analysis of cell-free fetal deoxyribose nucleic acid (cff-DNA) in the maternal plasma is considered as a valuable test for pregnant women, which provides early diagnosis of genetic disorders in fetus.

Further, advancements in genome sequencing technologies have reduced the turnaround time and lowered complexities associated with diagnosis. NGS technology provides several avenues to develop non-invasive diagnostic procedures for an early and accurate detection of various genetic disorders. This is driving several companies to invest in research and development of NGS-based NIPT products and develop innovative solutions for the market. For instance, in January 2019, Yourgene Health plc (U.K.) launched the Sage 32 plex test which uses Thermo Fisher’s Ion Torrent sequencing technology to detect placental cff-DNA in a maternal blood sample. Similarly, in September 2018, Yourgene Health formerly known as Premaitha Health plc. (U.K.) partnered with Illumina Inc. (U.S.) to use the Illumina’s sequencing technology for the NIPT test developed by Premaitha.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5068

Geographically, the global non-invasive prenatal testing market is segmented into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa with a further analysis of major countries in each region. North America commanded the largest share of the global non-invasive prenatal testing market in 2019, followed by Europe and Asia-Pacific region. The major share of the North American region is mainly attributed to the high diagnostic and treatment rate of trisomy disorders in the region, high awareness for prenatal testing, and presence of laboratories offering NIPT services in the region.

Some of the key players operating in the global non-invasive prenatal testing market are Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), PerkinElmer Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Eurofins LifeCodexx (Germany), Natera, Inc. (U.S.), Igenomix S.L (Spain), Laboratory Corporation of America Holdings (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and Yourgene Health plc (U.K.).

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5068

The growth in the overall NIPT market is majorly driven by factors like shifting trend towards childbirth at an advanced maternal age, increasing prevalence of chromosomal abnormalities, availability of reimbursement for NIPT, and development of advanced technologies for non-invasive parenteral testing. However, the high cost of the non-invasive prenatal screening techniques hinders the growth of this market.

European Fragrances Microencapsulation Market for Home and Personal Care Products to Reach $203.4 Million by 2027

 According to a new market research report titled “European Fragrances Microencapsulation Market for Home and Personal Care Products by Technology/Method [Physico-Mechanical (Spray Drying, Coextrusion); Physico-Chemical; Chemical]; Application (Home Care and Personal Care); and Country -Forecast to 2027” published by Meticulous Research®, the European fragrances microencapsulation market for home and personal care products is expected to grow at a CAGR of 2.9% from 2020 to 2027 to reach $203.4 million by 2027.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5144

Microencapsulation is a complex technique that involves the creation of shells, whether natural or synthetic, where particles of active ingredients and fragrances are stored and remain protected from the environment. Many home and personal care products contain active substances that require encapsulation for increased stability. Microencapsulation acts as an important home and personal care industry tool, enabling protection and controlled release of several active agents, like fragrances.

The growth of the European fragrances microencapsulation market for home and personal care products is mainly attributed to the strong growth in the cosmetics industry; increasing demand for home care products; growing demand for microencapsulated fragrances due to their wide applications across the home and personal care industries; and rising R&D investments for improving process efficiency. Technological advancements and emerging plastic-free encapsulation technologies provide significant opportunities for manufacturers in the European fragrances microencapsulation market. However, the high production costs of some microencapsulation processes and stringent regulatory requirements are expected to restrain the future growth of this market to some extent.

The European fragrances microencapsulation market for home and personal care products study presents historical market data in terms of value (2018 and 2019), estimated current data (2020), and forecasts for 2027 — by technology/method [physico-mechanical methods (spray drying, fluidized bed spray coating, coextrusion, spray chilling or congealing, other physico-mechanical methods); physico-chemical methods (coacervation or phase separation methods and other physico-chemical methods); chemical methods (in-situ polymerization and interfacial polymerization); and other microencapsulation methods]; application [personal care (skincare products, haircare products, deodorants and perfumes, other personal care products); home care (laundry detergents and fabric conditioners, house cleaning agents, other home care products); and geography. The study also evaluates industry competitors and analyzes the market at country levels.

This research report analyzes major European countries and provides a comprehensive analysis for Germany, France, the U.K., Italy, Spain, and other European countries. Germany is estimated to hold the largest share of the European fragrances microencapsulation market for home and personal care products in 2020, followed by France and the U.K. Also, the Germany is witnessing the rapid growth during the forecast period, owing to the increasing innovation in its personal care and cosmetics industry and strong growth in the home & personal care industry

The report includes an extensive assessment of the key strategic developments by leading market participants in the industry over the past four years (2016–2020). The European fragrances microencapsulation market for home and personal care products has witnessed several mergers and acquisitions, expansions, partnerships, agreements, and collaborations in recent years. The key players operating in the European fragrances microencapsulation market for home and personal care products are Givaudan S.A. (Switzerland), International Flavors & Fragrances, Inc.(U.S.), Calyxia S.A. (France), Follmann GmbH & Co. KG (Germany), Firmenich Incorporated (Switzerland), Symrise AG (Germany), Ingredion Incorporated (U.S.), MikroCaps d.o.o (Slovenia), Koehler Innovative Solutions (Germany), Ashland Global Holdings Inc. (U.S.), Robertet Group (France), Vantage Specialty Chemicals (U.S.), Euracli (France), Capsulæ SAS (France), Robert Blondel Cosmetiques (France), Lambson Ltd. (U.K.), and Micropore Technologies Limited (U.K.), among others.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5144